Institutional investors purchased a net $2.7 million shares of VRX during the quarter ended June 2015 and now own 87.02% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PAULSON & CO., INC. Bought 7.0 Million shares of Valeant Pharmaceuticals
TORONTO DOMINION (SOUTH EAST ASI... Bought 1.1 Million shares of Valeant Pharmaceuticals